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During neurogenesis, progenitors switch from self-
renewal to differentiation through the interplay of
intrinsic and extrinsic cues, but how these are inte-
grated remains poorly understood. Here, we combine
whole-genome transcriptional and epigenetic ana-
lyses with in vivo functional studies to demonstrate
that Bcl6, a transcriptional repressor previously re-
ported to promote cortical neurogenesis, acts as
a driver of the neurogenic transition through direct
silencing of a selective repertoire of genes belonging
to multiple extrinsic pathways promoting self-
renewal, most strikingly the Wnt pathway. At the
molecular level, Bcl6 represses its targets through
Sirt1 recruitment followed by histone deacetylation.
Our data identify a molecular logic by which a single
cell-intrinsic factor represses multiple extrinsic path-
ways that favor self-renewal, thereby ensuring
robustness of neuronal fate transition.
INTRODUCTION
During neural development, the generation of the appropriate
type and number of differentiated neurons and glial cells is
controlled by a complex interplay between extrinsic and intrinsic
cues acting on neural progenitors, thus regulating the balance
between differentiation and self-renewal (Martynoga et al.,
2012; Rossi et al., 2017; Tiberi et al., 2012b).
In the developing cortex, radial glial cells are the main progen-
itors that will differentiate into specific postmitotic neuron
populations, directly or through various classes of intermediate
progenitors (Go¨tz and Huttner, 2005; Kriegstein and Alvarez-
Buylla, 2009). Proneural factors act on these progenitors as the
main intrinsic drivers of neurogenesis (Guillemot and Hassan,Neuron 103, 1–13, Sept
This is an open access article under the CC BY-N2017; Guillemot et al., 2006), through cross-repression with the
Notch pathway, which promotes self-renewal, and by directly
inducing various classes of genes involved in neuronal differen-
tiation. Key features of the Notch signaling pathway, such as
lateral inhibition and oscillatory behavior, contribute in a major
way to the irreversible commitment of differentiating cells toward
neuronal fate (Kageyama et al., 2008). Moreover, many classes
of extrinsic morphogen cues, including Wnt ligands, Sonic
Hedgehog (SHH), and fibroblast growth factors (FGFs) can act
on cortical progenitors to promote expansion and self-renewal
and thereby effectively block neurogenesis (Chenn and Walsh,
2002; Kang et al., 2009; Lien et al., 2006; Rash et al., 2011;
Wang et al., 2016).
Intriguingly, it has long been proposed that postmitotic cells
undergoing neuronal differentiation become insulated from
extrinsic signaling (Edlund and Jessell, 1999). Whether and
how responsiveness to extrinsic cues is negatively modulated
to allow neuronal commitment remains essentially unclear.
Delamination of the progenitors away from the ventricular zone
could contribute to this process, as some of these cues are
secreted in the embryonic cerebrospinal fluid and are thought
to act through the apical processes or cilia of the radial glial cells
(Lehtinen et al., 2011). However, several cues, most strikingly
Wnts, are also present in the cortical tissue (Harrison-Uy and
Pleasure, 2012), where they can act on progenitors to block
differentiation.
Moreover, the signaling components of these various path-
ways, aswell as some key downstream targets, are often partially
overlapping. For instance, cross-talk of the Notch and Wnt path-
ways (Hayward et al., 2008), or Notch and FGFs (Rash et al.,
2011), has been documented during embryonic development
and, despite the relatively simple intracellular regulation of the
Wnt/b-catenin pathway, many of its components are used
by other pathways or participate in distinct cellular activities.
For instance, the deletion of Gsk3a/b, a major intracellular
component of the b-catenin destruction complex, increases the
proliferation of radial glial cells at the expense of their differentia-
tion by altering not only Wnt but also Notch and FGF signalingember 25, 2019 ª 2019 The Author(s). Published by Elsevier Inc. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Bcl6 Promotes a Neurogenic Transcription Program and Represses Selective Genes of the Main Proliferative Pathways
(A) Scheme representing the differentiation protocol of Bcl6-inducible A2 lox.Cre mouse embryonic stem cells into cortical progenitors. Bcl6 expression was
induced at day 12 using a single doxycycline pulse for 24 h.
(B) Gene Ontology analysis showing statistically significant enrichment for some categories of up- and downregulated genes following Bcl6 induction (see also
Table S2 for complete lists).
(C) Histograms representing the log-fold change of a series of significantly up- or downregulated genes, respectively indicated in red or blue, selected upon their
expression and/or function during cortical differentiation. IP, intermediate progenitors; NE, neuroepithelial cells; RGC, radial glial cells (see also Table S1 for
complete lists).
(D) Histograms representing the log-fold change of significantly up- or downregulated genes, respectively indicated in red or blue, belonging to the main
proliferative pathways in cortical progenitors. Only the potential target genes with known expression in embryonic cortical progenitors are indicated. For the
complete list of genes taken into consideration for the analysis, see also Table S3. Genesmarked with an asterisk also are target genes of the pathway itself. SVZ,
subventricular zone; VZ, ventricular zone.
(E) Scheme of the canonical Wnt pathway depicting the role in the cascade of the ensemble of Wnt/b-catenin-related genes bound and/or altered by Bcl6
investigated in this study.
(legend continued on next page)
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Cyclin d1/d2, are found as common targets of all morphogen
pathways, depending on cellular context (Cohen et al., 2010;
Kalita et al., 2013; Katoh and Katoh, 2009; Nilsson et al., 2012;
Shtutman et al., 1999). How these intermingled pathways are
effectively shut down during neurogenesis is therefore a complex
issue and remains largely unresolved.
We previously reported that the transcriptional repressor Bcl6
(Baron et al., 1993; Chang et al., 1996) is required for neuronal
differentiation in the cerebral cortex and directly represses the
Notch-dependent Hes5 target (Tiberi et al., 2012a), and in the
cerebellum, Bcl6 promotes neurogenesis through repression of
SHH pathway effectors Gli1/2 (Tiberi et al., 2014). This raises
the question whether Bcl6 promotes neurogenic conversion
through the repression of distinct targets, depending on the
cellular context, or through a more generic transcriptional
repression program.
Here, we combine transcriptome, epigenome, and in vivo
functional analyses to determine the molecular logic of action
of Bcl6 during neurogenesis, focusing on the cerebral cortex.
We find that Bcl6 acts as a global repressor of a repertoire of
signaling components of most signaling pathways known to
promote self-renewal, including Notch, SHH, FGF, and most
strikingly the Wnt pathway. These data define a molecular logic
of neurogenesis whereby a single intrinsic factor downregulates
the responsiveness to extrinsic cues, through transcriptional
repression at multiple parallel and serial levels along these path-
ways, to ensure irreversible neurogenic fate transition.
RESULTS
Bcl6 Upregulates an Intrinsic Neurogenic Program and
Downregulates Extrinsic Proliferative Pathways
To determine the primary molecular mechanisms of Bcl6 action
in cortical neurogenesis, we performed RNA sequencing (RNA-
seq) transcriptome analysis on in vitro embryonic-stem-cell-
derived cortical progenitors driving inducible Bcl6 expression
in order to timely control the transgene induction (Figure 1A;
Gaspard et al., 2008; Tiberi et al., 2012a). We found that, 24 h
following Bcl6 induction, 764 genes were significantly upregu-
lated, with Bcl6 being the most increased, and 610 genes were
significantly downregulated, withHes5 being themost repressed
(Table S1).
Gene Ontology analysis of the upregulated genes revealed a
significant enrichment in categories linked to development and
cell or neuron differentiation (Figure 1B; Table S2). More specif-
ically, most of the canonical markers of differentiation into inter-
mediate progenitors and neurons were significantly upregulated
(Figure 1C; Table S1). On the other hand, downregulated genes
showed an enrichment in gene categories linked to regulation of
translation, negative regulation of neurogenesis, and most strik-
ingly to signaling pathways promoting the expansion and self-
renewal of cortical progenitors (Figure 1B; Table S2). Among(F) qRT-PCR analysis of the Notch target Hes5, Wnt-related genes Ctnnb1 and
cortical progenitor cells treated with DMSO (control) or doxycycline for 6, 12, or
levels (n = 7–9 [6 h], 27–30 [12 h], and 9 [24 h] from at least 3 independent differe
Figure S1.the significantly downregulated genes, we found, as expected,
markers of radial glial cells and transcriptional targets of Notch
but also many signaling components of FGF and SHH-depen-
dent pathways and, most strikingly, a high number of genes
belonging to the Wnt signaling cascade, from ligands to recep-
tors to target genes (Figures 1C–1E; Tables S1 and S3). Given
that Bcl6 has strong effects on neurogenesis, it could be that
these global transcriptional changes reflect the consequence
of changes in cell fate rather than direct regulation by Bcl6.
However, the majority of the tested genes belonging to these
proliferative pathways (8/11) were downregulated following
Bcl6 induction several hours earlier than changes in cell fate
markers (Figures 1F and S1A), indicating that their downregula-
tion is not the mere result of Bcl6-mediated differentiation.
Bcl6 Functionally Alters b-Catenin/Tcf Signaling to
Promote Neurogenesis
Given the importance of the Wnt pathway in the regulation of
self-renewal versus differentiation balance in the cortex (Chenn
and Walsh, 2002; Fang et al., 2013; Hirabayashi and Gotoh,
2005; Hirabayashi et al., 2004; Kuwahara et al., 2010; Munji
et al., 2011; Mutch et al., 2010; Wrobel et al., 2007; Zhang
et al., 2010) and the number of downregulated genes belonging
to this pathway, we tested the global impact of Bcl6 on the Wnt
pathway in vivo. Axin 2, a classical Wnt/b-catenin-dependent
target gene, was found to be upregulated in Bcl6/ mouse
embryonic cortex using in situ hybridization. Although Axin2
expression is normally detected in the medial pallium of the fron-
tal cortex in wild-type animals, a higher signal was found
throughout dorsolateral levels in Bcl6/ mice (Figures 2A and
2B), suggesting that b-catenin/Tcf activity is increased in the
mutant cortex. Interestingly, this difference was not detectable
at more posterior levels (Figures 2A and 2B), in accordance
with the frontal high occipital low graded Bcl6 expression (Tiberi
et al., 2012a). Given that these gene expression changes are
specific to the frontal cortex, we tested whether they could affect
areal patterning in the mutant mice. However, analysis of the
pattern of expression of several area-specific markers did not
detect any obvious changes in areal patterning in the Bcl6
mutant mice (Figures S2A–S2J), suggesting that Bcl6 effect on
the Wnt pathways does not affect regional patterning of the
cortex.
On the other hand, these data suggest that Bcl6 neurogenic
function could depend on the downregulation of the canonical
Wnt pathway. We first tested this in vitro by examining potential
genetic interactions between Bcl6 and b-catenin, the main
signaling hub protein of the pathway. Neurogenic genes upre-
gulated in vitro by Bcl6 were prevented by CHIR99021, a
GSK3 inhibitor over-activating the canonical Wnt pathway.
CHIR99021, which increased the levels of the Wnt reporter
gene Lef1, also prevented Bcl6-mediated downregulation of
Wnt target genes but did not prevent repression of Notch tar-
gets (Figure S2K).Ccnd2, and the cell fate markers Pax6, Eomes, and Tubb3 in day 12 in vitro
24 h. Data are presented as mean + SEM of Dox over control (Ctrl) absolute
ntiations for each group). *p < 0.05; **p < 0.01 using Student’s t test. See also
Neuron 103, 1–13, September 25, 2019 3
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Figure 2. Bcl6 Alters b-Catenin Signaling In Vivo to Promote Neurogenesis
(A) In situ hybridization of Axin2 Wnt reporter gene on coronal sections of E12.5 wild-type and Bcl6/ frontal and parietal telencephalon. Scale bars, 500 mm.
(B) Normalized gray scale quantifications of Axin2 levels were performed using ImageJ software. Data are presented as mean + SEM. *p < 0.05 using Student’s
t test.
(C–E) In utero electroporation of pCIG, pCIG+pCAG-D(1-90)Ctnnb1, pCIG-Bcl6+pCIG or pCIG-Bcl6+pCAG-D(1-90)Ctnnb1 at E13.5.
(C) Hoechst and GFP immunofluorescence was performed on coronal sections of E15.5 brains. Dashed lines mark the basal and apical margins of the VZ, SVZ,
intermediate zone (IZ), and cortical plate (CP). Scale bar, 50 mm.
(legend continued on next page)
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stabilized b-catenin mutant on Bcl6 overexpression using
in utero electroporation. Bcl6 gain of function alone led to
increased neurogenesis, as assessed by increased number of
cells in the cortical plate (CP) and an increase in Neurod2+ and
Tuj1+ neurons, at the expense of ventricular zone (VZ)-located
Pax6+ and Sox2+ progenitors, without detectable effect on
neuronal migration or progenitor delamination (Figures 2C–2E
and S3A–S3G). Importantly, these effects were suppressed by
overexpression of stabilized b-catenin (Figures 2C–2E and S4C).
Conversely, we combined Bcl6 and b-catenin (Ctnnb1) knock-
down to assess potential epistasis. As expected (Tiberi et al.,
2012a), Bcl6 knockdown led to decreased neurogenesis per
se, as reflected by increased cell number in the VZ at the
expense of the CP, associatedwith increased levels of radial glial
cell progenitors and decreased neurons (Figures 2F–2H and
S3H–S3N), and this phenotype was significantly rescued by
the Ctnnb1 knockdown (Figures 2F–2H).
These data collectively suggest that Bcl6 functionally acts on
the Wnt pathway to promote neurogenesis, in addition to its
effect on the Notch target Hes5 (Tiberi et al., 2012a). We next
directly compared the impact of Bcl6 onWnt andNotch pathways
in vivo by combining Ctnnb1 and Hes5 short hairpin RNAs
(shRNAs) to further assesswhetherBcl6 represses them inparallel
or sequentially. Hes5 knockdown rescued some of the Bcl6 loss-
of-function-mediated phenotype to levels similar to the rescue
obtained using theCtnnb1 knockdown. However, the association
of both Ctnnb1 and Hes5 shRNAs showed additive rescue of
Bcl6 knockdown, reaching the corresponding control levels
(Ctnnb1+Hes5 shRNA combination; Figures 2F–2H), suggesting
that Bcl6 alters these two cascades at least in part in parallel.
Altogether, these data indicate that Bcl6-mediated repression
of the Wnt pathway, already at the level of b-catenin, is neces-
sary to elicit neurogenic activity, in parallel to Notch signaling
repression. Thus, Bcl6 acts by repression of multiple pathways
promoting progenitor self-renewal and proliferation.
As b-catenin is not only a key component of the Wnt pathway
but also an important regulator of adherens junctions (Nelson
and Nusse, 2004), we tested further the specific implication of
the Wnt pathway by focusing on Tcf7l1, which was also found
to be downregulated in response to Bcl6 in vitro (Figure S1A)(D) Histograms show the percentage of GFP+ cells in VZ, SVZ, IZ, andCP. **p < 0.0
D(1-90)Ctnnb1 versus pCIG-Bcl6+pCIG using two-way ANOVA followed by Tuke
(E) Histograms show the percentage of Pax6+ and Tuj1+ cells among the GF
###p < 0.001 pCIG-Bcl6+pCAG-D(1-90)Ctnnb1 versus pCIG-Bcl6+pCIG using on
Data are presented as mean + SEM of n = 6 control embryos (1,856 cells), n = 10 e
Bcl6 gain of function (1,922 cells), and n = 9 embryos for Bcl6 and stabilized b-c
(F–H) In utero electroporation of scramble (control), scramble+Ctnnb1, scramb
scramble+Hes5+Bcl6, and Ctnnb1+Hes5+Bcl6 shRNAs at E13.5.
(F) Representative images of Hoechst and GFP immunofluorescence performed
margins of the VZ, SVZ, IZ, and CP. Scale bar, 50 mm.
(G) Histograms show the percentage of GFP+ cells in VZ, SVZ, IZ, and CP. *p < 0
Bcl6+control shRNAs using two-way ANOVA followed by Tukey post hoc test.
(H) Histograms show the percentage of Pax6+ and b3-tubulin+ cells among th
###p < 0.001 versus Bcl6+control shRNAs using one-way ANOVA followed by Tu
Data are presented as mean + SEM of n = 15 control embryos (4,476 cells), n = 7 e
cells), n = 7 embryos forCtnnb1+Hes5 shRNA (1,932 cells), n = 6 embryos forBcl6
embryos for Bcl6+Hes5 shRNA (2,614 cells), and n = 9 embryos for Bcl6+Ctnnb
See also Figures S2, S3, and S4.and is the most heavily expressed Tcf/Lef transcription factor
in cortical progenitors (Galceran et al., 2000).
Remarkably, we found that overexpression of Tcf7l1 blocked
Bcl6-mediated neurogenesis in vivo (Figures S4A–S4D). Hence,
these data strongly suggest that b-catenin downregulation by
Bcl6 is mostly linked to its Wnt-related transcriptional activity
rather than its activity in adherens junctions. This is in line with
our RNA-seq analyses, which show that the expression of most
genes related to adherens junctions tend to increase upon Bcl6
overexpression, especially Jup/g-catenin (Figure S1B), thereby
compensating b-catenin decrease, as previously reported (Wick-
line et al., 2013).
Bcl6 PromotesNeurogenesis throughCyclinD Inhibition
Although Bcl6 appears to repress multiple serial components of
individual pathways, it could also act through common effectors
of parallel signals. In linewith this hypothesis,Cyclin d1/d2 genes
were found to be downregulated by Bcl6 overexpression in vitro
(Figure 1D; Table S1) and are known to be upregulated by path-
ways driving progenitor self-renewal, including Wnt (Shtutman
et al., 1999) but also SHH (Kasper et al., 2006; Katoh and Katoh,
2009), FGF-insulin growth factor (IGF) (Kalita et al., 2013; Nilsson
et al., 2012), and Notch (Cohen et al., 2010). Moreover, Cyclin
d1/d2 are key promoters of cortical progenitor proliferation
and consequently block neurogenesis (Lange et al., 2009; Pilaz
et al., 2009; Tsunekawa et al., 2012).
We first examined their expression in the developing cortex in
wild-type and Bcl6/ brains. Ccnd1 was found in the VZ and
SVZ in wild-type mice as previously reported (Glickstein et al.,
2007), and its levels were significantly increased in Bcl6/ ani-
mals (Figures 3A and 3B). Ccnd2 mRNA was mostly detected
in basal endfeet of radial glial cells and at lower intensity in the
ventricular zone at embryonic day 12.5 (E12.5), as previously
described (Tsunekawa et al., 2012). Although the high density
of labeling and limited resolution of in situ hybridization pre-
cluded detecting upregulation in the basal endfeet, Ccnd2
levels were significantly increased in the VZ in Bcl6/ cortex
(Figures 3C and 3D). Hence, Bcl6 negatively controls Ccnd1/2
expression in cortical progenitors in vivo. We next examined
the functional impact of Bcl6 loss of function on Ccnd1/Ccnd2
double knockdown, as these two cyclins regulate cell cycle1 pCIG-Bcl6+pCIG versus pCIG and #p < 0.05, ###p < 0.001 pCIG-Bcl6+pCAG-
y post hoc test.
P+ cells. **p < 0.01, ***p < 0.001 pCIG-Bcl6+pCIG versus pCIG+pCIG and
e-way ANOVA followed by Tukey post hoc test.
mbryos for stabilized b-catenin gain of function (2,727 cells), n = 9 embryos for
atenin double gain of function (1,588 cells).
le+Hes5, scramble+Ctnnb1+Hes5, scramble+Bcl6, scramble+Ctnnb1+Bcl6,
on coronal sections of E16.5 brains. Dashed lines mark the basal and apical
.05, **p < 0.01, ***p < 0.001 versus control and #p < 0.05, ###p < 0.001 versus
e GFP+ cells. *p < 0.05, **p < 0.01 versus control and #p < 0.05, ##p < 0.01,
key post hoc test.
mbryos forCtnnb1 shRNA (1,851 cells), n = 13 embryos forHes5 shRNA (3,893
shRNA (2,093 cells), n = 9 embryos forBcl6+Ctnnb1 shRNA (2,642 cells), n = 10
1+Hes5 shRNA (2,993 cells).
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Figure 3. Bcl6 Directly Affects Ccnd1/Ccnd2 Expression In Vivo to Promote Neurogenesis
(A–D) In situ hybridization of (A) Ccnd1 and (C) Ccnd2 genes on coronal sections of E12.5 wild-type and Bcl6/ frontal and parietal telencephalon. Normalized
gray scale quantifications of (B) Ccnd1 and (D) Ccnd2 levels were performed using ImageJ software. Data are presented as mean + SEM. *p < 0.05, **p < 0.01
using Student’s t test. Black scale bars, 500 mm. Red scale bar, 100 mm.
(E–G) In utero electroporation of scramble (control), scramble+Ccnd1+Ccnd2, scramble+Bcl6, and Ccnd1+Ccnd2+Bcl6 shRNAs at E13.5.
(E) Representative images of Hoechst and GFP immunofluorescence performed on coronal sections of E16.5 brains. Dashed lines mark the basal and apical
margins of the VZ, SVZ, IZ, and CP. Scale bar, 50 mm.
(F) Histograms show the percentage of GFP+ cells in VZ, SVZ, IZ, and CP. *p < 0.01, **p < 0.01 versus control and ###p < 0.001 versus Bcl6+control shRNAs using
two-way ANOVA followed by Tukey post hoc test.
(G) Histograms show the percentage of Pax6+ and b3-tubulin+ cells among the GFP+ cells. **p < 0.01, ***p < 0.001 versus control and ###p < 0.001 versus
Bcl6+control shRNAs using one-way ANOVA followed by Tukey post hoc test.
Data are presented as mean + SEM of n = 12 control embryos (3,627 cells), n = 7 embryos for Ccnd1+Ccnd2 shRNA (1,519 cells), n = 8 embryos for Bcl6 shRNA
(1,998 cells), and n = 12 embryos for Bcl6+Ccnd1+Ccnd2 shRNA (3,475 cells).
See also Figures S3 and S4.
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Figure 4. Bcl6 Binds to Core Genes of the Wnt/b-Catenin Pathway to Alter Their Expression
(A) qRT-PCR analysis of Wnt-related genes from DMSO- and doxycycline-treated cells at day 12. Data are presented as mean + SEM of absolute levels (n = 21
from 8 differentiations). *p < 0.05 and **p < 0.01 using Student’s t test.
(B) ChIP-qPCR validation of screened Bcl6-binding sites on regulatory regions and negative control sites of significantly downregulated Wnt-related genes in
E12.5 wild-type and Bcl6/ telencephalon using a Bcl6 antibody. Data are presented as mean + SEM of input enrichment (n = 4). *p < 0.05, **p < 0.01, and ***p <
0.001 using Student’s t test. Genes are represented using 50 to 30 orientation with light blue showing 50 UTR and 30 UTR exons and thicker dark blue showing the
exons of the coding sequence and the introns according to RefSeq gene sequences from mouse genome mm10 assembly (https://genome.ucsc.edu). Black
boxes indicate amplified regions (BS, region comprising the Bcl6-predicted binding site inside the ChIP-seq significant peaks; NEG, region with no predicted Bcl6
matrix using the Jaspar software [http://jaspar.genereg.net]).
See also Figures S5 and S6.
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Glickstein et al., 2007; Tsunekawa et al., 2012). Decreased neu-
rogenesis observed following Bcl6 shRNA was completely
rescued by the dual Ccnd1/Ccnd2 knockdown (Figures 3E–3G
and S4E–S4G). Conversely, Ccnd1 overexpression blocked
Bcl6-elicited neurogenesis in vivo (Figures S4A–S4D). This indi-
cates that, in addition to repressing specific signaling pathway
components, Bcl6 action also involves repression of common
terminal effector targets, such as Ccnd1/2, driving progenitor
proliferation and self-renewal.
Bcl6 Represses Transcription through Sirt1-Mediated
Histone Deacetylation as well as Target-Specific
Mechanisms
Overall, our data indicate that Bcl6 acts through inhibition of
multiple pathways to promote neurogenesis, raising the question
of which effects are directly related to Bcl6 transcriptional repres-
sionor reflect its indirect consequences. To address this point, we
performed chromatin immunoprecipitation (ChIP)-seq to identify
Bcl6 binding sites using in vitro cortical progenitors driving induc-
ibleBcl6expression inorder to increase theefficiencyof the immu-
noprecipitation (Figure S5). This revealed that Bcl6 binding was
predominantly found on promoter regions, with a significant
enrichment for Bcl6 matrix binding motif (Figures S5A–S5D).
Further, 39% of the Bcl6-predicted targets (1,701/4,366 peak-
associated genes) were similar to those previously reported by
ChIP-seq in humanBcells (Basso et al., 2010). In linewithour tran-scriptomics data, Bcl6 bound to numerous genes of the multiple
cascades regulating the proliferation of cortical progenitors (Fig-
ure S5E), although it should be noted that only 19% of the down-
regulated genes from the RNA-seq dataset were found in the
ChIP-seq screen (115/610 genes), indicating partial discrepancy
between transcription factor binding and transcriptional effect,
at least at the time points tested.
Then we validated in vivo some of these targets using ChIP-
qPCR on the identified binding peaks in E12.5 wild-type and
Bcl6/ cortex, focusing on Wnt and Notch pathways. We first
confirmed Bcl6 binding to the Notch target Hes5 but also
identified additional Bcl6/Notch targets, such asHes1 andNrarp
(Figures 4 and S6A). Moreover, we found that Bcl6 bound to a
repertoire of VZ-expressed genes of the Wnt/b-catenin cascade
as well as potential Wnt/b-catenin targets, among which 10
showed significant downregulation upon Bcl6 induction in
in vitro embryonic stem cell (ESC)-derived cortical progenitors,
whether by RNA-seq or qRT-PCR, suggesting a direct functional
impact following Bcl6 binding (Figures 4A and S6D). The genes
bound and regulated by Bcl6 ranged from Wnt receptors and
co-receptors to intracellular effectors to Wnt target genes (Fig-
ures 1E, 4B, and S6E).
We next examined how Bcl6 binding to its target sequences
might lead to transcriptional repression. We previously found
that Bcl6-mediated Hes5 repression occurs through modifica-
tions of histone acetylation mediated by Sirt1 deacetylase
recruitment (Tiberi et al., 2012a). Remarkably, we found a similarNeuron 103, 1–13, September 25, 2019 7
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Figure 5. Bcl6 Binding to Significantly Downregulated Wnt-Related Genes Induces Chromatin Remodeling and Sirt1 Recruitment
(A) ChIP-qPCR of histone acetylation marks on Bcl6 binding sites of significantly downregulatedWnt-related genes in E12.5 wild-type and Bcl6/ telencephalon
using control (rabbit immunoglobulin G [IgG]) and H1.4K26ac and H4K16ac antibodies. Data are presented as mean + SEM of input enrichment (n = 6). *p < 0.05
and **p < 0.01 using Student’s t test.
(B) ChIP-qPCR on validated Bcl6 binding sites of significantly downregulated Wnt-related genes in E12.5 wild-type and Bcl6/ telencephalon using a
Sirt1 antibody. Data are presented as mean + SEM of input enrichment (n = 6). *p < 0.05, **p < 0.01, and ***p < 0.001 using Student’s t test.
See also Figure S6.
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Indeed, in vivo ChIP-qPCR experiments performed on mouse
E12.5 embryonic cortex showed enrichment for acetylated ly-
sines H4K16 and H1.4K26 on all tested genes in Bcl6/ cortex
compared with wild-type, indicating that repressive chromatin
remodeling required the presence of Bcl6 binding (Figures 5A
and S6B). Moreover, we detected binding of the histone deace-
tylase Sirt1 to all Bcl6-bound target genes, which was abolished
in Bcl6/ cortex (Figures 5B and S6C).
To test whether Sirt1 activity was indeed required for Bcl6 ac-
tivity, we examined in more depth the transcriptional regulation
of Ccnd1/2. Bcl6 was found to bind to their regulatory regions
in vitro, together with Sirt1, in association with histone H4K16
deacetylation, as observed in vivo (Figure 6). Furthermore, we
found that sirtuin activity inhibition effectively blocked the
Bcl6-mediated Ccnd1/2 downregulation, confirming the impor-
tance of Sirt1-dependent histone deacetylation in the repression
of these genes by Bcl6 (Figure S7A).
These data point to a generic mechanism by which a wide
repertoire of the genes downregulated by Bcl6 and belonging
to stem-cell-renewal signaling pathways are directly bound
and repressed by Bcl6, which then recruits Sirt1, leading to their
transcriptional silencing.8 Neuron 103, 1–13, September 25, 2019On the other hand, given the important role of Tcf7l1 in Bcl6
effects on neurogenesis, we examined in more detail the
chromatin binding profiles of Tcf7l1 on the Ccnd1/2 regulatory
regions (Figure 6). This revealed that Tcf7l1 bound to both
Ccnd1/2 promoters on predicted Tcf/Lef binding sites, confirm-
ing their direct link with the Wnt pathway (Figure 6). Remark-
ably, this binding was decreased upon Bcl6 overexpression
(Figure 6B). In contrast, Tcf7l1 binding at the level of the Lef1
promoter, to which Bcl6 does not bind to, was unaffected (Fig-
ures S7B and S7C). These data thus suggest that Bcl6 directly
affects Tcf7l1 binding in a target-specific way, as an additional
selective mechanism to modulate Wnt-dependent gene
expression.
DISCUSSION
Neurogenesis is a key fate transition controlled by the interplay of
intrinsic and extrinsic cues, but how these are integrated at the
molecular level remains mostly unknown. Here, we identify the
Bcl6 transcriptional repressor as a neurogenic factor that acts
through the direct repression of a repertoire of genes encoding
key components of numerous extrinsic morphogen pathways
that promote self-renewal andproliferation of cortical progenitors,
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Figure 6. Bcl6 and Sirt1 Bind to Ccnd1 and Ccnd2 Regula-
tory Regions, Leading to the Removal of the b-Catenin Effector
Tcf7l1
(A) Schematic representation of the genomic region 2 kb upstream of Ccnd1
and Ccnd2 transcription starting sites showing validated Bcl6 (red) as well as
putative Tcf7l1 (blue) binding sites and negative regions for either transcription
factor (green) as predicted by the Jaspar software (http://jaspar.genereg.net).
The arrows represent the amplified regions by qPCR used to measure the
enrichment following ChIP.
(B) ChIP-qPCR analysis of the Bcl6, Sirt1, and Tcf7l1 binding sites on the
Ccnd1 and Ccnd2 regulatory regions in cortical progenitors derived from
Bcl6 A2 lox.Cre mouse ESCs (differentiation day 12, 24 h DMSO [Ctrl]
or Dox treatment). Data are presented as mean + SEM of input enrichment
(n = 3 differentiations). *p < 0.05, **p < 0.01, and ***p < 0.001 using Stu-
dent’s t test.
(C) ChIP-qPCR analysis of the H4K16ac histone acetylation mark on Bcl6
binding sites of theCcnd1 andCcnd2 regulatory regions in cortical progenitors
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Renewal-Promoting Extrinsic Pathways, Neuron (2019), https://doi.org/10.1016/j.neuron.2019.06.027most strikingly the Wnt pathway. This provides important insight
on themolecular logic by which neurogenic conversion can occur
in a robust fashion in the presence of many, and sometimes con-
tradictory, extrinsic cues.
Our transcriptome analysis shows that Bcl6 gain of function
elicited a broad neurogenic program, from genes involved in
the generation and expansion of intermediate progenitors to
their differentiation into neurons, as well as neuronal maturation
and specification, similarly to the response to the proneural
Neurog2 transcription factor in the developing cortex (Gohlke
et al., 2008; Johnson et al., 2015). However, in the case of
Bcl6, these effects are caused by a direct negative impact of
Bcl6 on pathways promoting self-renewal and proliferation.
Indeed, Bcl6 represses the transcription of genes related to
most signaling cascades that favor the proliferation of cortical
progenitors at the expense of their differentiation, most strik-
ingly, the Notch and Wnt pathways, as well as SHH and FGF.
Combining our RNA-seq results with ChIP experiments, we
found that Bcl6 directly binds to most of these genes, leading
to their transcriptional repression, even if future work will be
needed to describe in depth Bcl6 direct repression on pathways
other than Notch and Wnt.
This global effect is conceptually similar to the one previously
proposed for Myt1l in the frame of neuronal reprogramming,
where a single transcription factor appears to repress globally
multiple non-neuronal fates to promote in vitro conversion into
neurons (Mall et al., 2017). It is also complementary to the clas-
sical effects of the Rest complex, which represses neuronal fate
genes in non-neuronal cells (Ballas et al., 2005). In the case of
Bcl6, however, the repression does not appear to act on fate-
specific genes per se but rather on specific genes involved in
extrinsic signaling pathways promoting progenitor maintenance.
In this sense, Bcl6 acts probably mostly during fate transition it-
self, and this molecular logic could thereby explain how neuronal
differentiation takes place irreversibly, even in the presence of
proliferative extrinsic cues, thus providing robustness to the neu-
rogenesis processes.
Interestingly, in the case of Wnt signaling, Bcl6 appears to act
upon multiple components, from receptors to transducers and
transcriptional effectors, as attested by the functional interac-
tions between Bcl6 and b-catenin and Tcf7l1, as well as with
Ccnd1/2, revealed in this study. This implies that, although
Bcl6 can alter the intracellular response of Notch signaling in a
target-specific way (Sakano et al., 2010; Tiberi et al., 2012a),
its effect on Wnt signaling appears to be much more global,
from responsiveness to output. This may be related to the high
complexity of the Wnt pathway, such as multiplicity of ligands
and receptors and cell-dependent positive and negative feed-
back loops (Clevers and Nusse, 2012; MacDonald et al., 2009),
on which acting at multiple levels of repression may be required
to achieve its robust silencing. Indeed, it should be noted that,
although many of the Wnt components that are repressed
are positive regulators of the pathway, some inhibitors of thederived from Bcl6 A2 lox.Cre mouse ESCs (differentiation day 12, 24 h
DMSO [Ctrl] or Dox treatment). Data are presented as mean + SEM of input
enrichment (n = 3 differentiations). *p < 0.05 using Student’s t test.
See also Figure S7.
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activators, such as Fzd8, or inhibitors, such as Dkk1, were,
most likely indirectly, upregulated. The same is true for the other
examined morphogen pathways, thus suggesting that, although
the overall effect of Bcl6 on these pathways is inhibitory, the net
effect on some individual genes could sometimes result in tran-
scriptional activation.
Moreover, the comparison of combined epistasis of Bcl6 with
Hes5 andCtnnb1 revealed that Bcl6 appears to affect Notch and
Wnt signaling in a parallel fashion rather than through a cascade
of events following the alteration of a single upstream pathway.
Furthermore, some Bcl6-elicited gene expression changes
impact several pathways at the same time. For instance, we
observed that Bcl6 gain of function decreases the expression
of Jag1 and Nrarp, which are both linked to Notch but also
Wnt pathways (Ishitani et al., 2005; Phng et al., 2009).
We identify Ccnd1 and Ccnd2 as major key targets of Bcl6,
and their downregulation rescues to a large extent the loss of
Bcl6. Ccnd1 or Ccnd2 were previously shown to act as key
promoters of cortical progenitor proliferation and blockers of dif-
ferentiation (Lange et al., 2009; Pilaz et al., 2009; Tsunekawa
et al., 2012) and are found downstream of most signaling path-
ways promoting progenitor self-renewal. This suggests a model
whereby Bcl6 contributes to robustness of fate transition by also
acting on key common downstream targets.
In principle, Ccnd1/2 regulation by Bcl6 could contribute to
other aspects of cortical development, such as area patterning
(Miyama et al., 1997), given Bcl6 preferential expression in the
frontal cortex and its effects on signaling cues, such as Wnts
and FGFs that can also impact on cortical areal patterning (Sur
and Rubenstein, 2005; Tiberi et al., 2012a). However, our ana-
lyses of the cortex of Bcl6 knockout mice failed to reveal any
alteration in areal patterning, indicating that Bcl6 essential func-
tion is on the regulation of neurogenesis itself.
From a molecular viewpoint, Bcl6 appears to act through the
same generic mechanism on most, if not all, of its targets, i.e.,
direct repression and Sirt1 recruitment, together with histone
deacetylation that is correlated with decreased transcription.
Interestingly, Bcl6 expression is progressively increased during
the transition of radial glia cells into neurons either directly or
indirectly though the generation of intermediate progenitors
(Tiberi et al., 2012a), and Sirt1 expression appears to be constant
in all cell types during cortical development (Ayoub et al., 2011;
Loo et al., 2019). Thus, the induction of Bcl6 expression and/or
post-transcriptional mechanisms could precisely regulate the
activity of the Bcl6-Sirt1 complex during the neurogenic transi-
tion; it will be interesting to identify whether this relies on extrinsic
cues or intrinsic factors.
One striking effect of Bcl6 is direct repression of b-catenin,
which is a key mediator of the Wnt pathway but also a critical
regulator of adherens junctions, which are essential for proper
function of radial glia progenitors (Go¨tz and Huttner, 2005). It is
therefore critical to disentangle the involvement of b-catenin
either on cell adhesion or Wnt signaling (Valenta et al., 2011).
In this frame, our data point to the conclusion that Bcl6-mediated
repression of b-catenin to induce neurogenesis is mostly related
to Wnt-dependent transcription and not on adherens junction
regulation, which are likely to be maintained despite b-catenin10 Neuron 103, 1–13, September 25, 2019downregulation through compensatory mechanisms, such as
upregulation of g-catenin (Wickline et al., 2013).
Moreover, in relation with b-catenin transcriptional activity, our
data indicate that Tcf7l1 is a key mediator of Wnt signaling that is
directly downstreamof Bcl6.Wnt activation has been reported to
have differential effects on neurogenesis (Chenn and Walsh,
2002; Fang et al., 2013; Hirabayashi and Gotoh, 2005; Hirabaya-
shi et al., 2004; Kuwahara et al., 2010; Munji et al., 2011; Mutch
et al., 2010; Wrobel et al., 2007; Zhang et al., 2010), and Tcf7l1
was previously proposed to act either as a repressor or an acti-
vator of transcription of Wnt-specific genes (Cole et al., 2008;
Kim et al., 2000; Lu et al., 2015; Shy et al., 2013; Wu et al.,
2012; Yi et al., 2011). However, our data indicate that, in the
context of Bcl6 effects on neurogenesis, Tcf7l1 acts mostly as
a blocker of neurogenesis, in line with previous findings (Ohtsuka
et al., 2011), and thereby likely as an activator of pro-proliferative
genes, such as Ccnd1/2 identified in this study.
To sum up, our data identify a major role for Bcl6 during neuro-
genesis by the direct transcriptional repression of most signaling
pathways promoting cortical progenitor self-renewal. As Bcl6 is
expressed in only specific subsets of progenitors and neurons
during brain development, future work should determine whether
and how other transcriptional repressors in other parts of the
nervous system can modulate responsiveness to extrinsic cues
to ensure robust and irreversible neurogenic fate transition.
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Genetically Modified Organisms
Bcl6tm2Rdf/Bcl6tm2Rdf mouse Ye et al., 1997 MGI Cat# 3582783, RRID: MGI:3582783
Antibodies
Chicken anti-GFP Abcam Cat# ab13970, RRID: AB_300798
Rabbit anti-Pax6 Covance Cat# PRB-278P, RRID: AB_291612
Mouse anti-b3-tubulin (Tuj1) Covance Cat# MMS-435P, RRID: AB_2313773
Goat Sox2 Santa Cruz Biotechnology Cat# sc-17320, RRID: AB_2286684
Mouse PCNA Millipore Cat# MAB424, RRID: AB_95106
Rat Phospho-Histone H3 Abcam Cat# ab10543, RRID: AB_2295065
Rabbit Tbr2 Abcam Cat# ab183991, RRID: AB_2721040
Rabbit Neurod2 Abcam Cat# ab104430, RRID: AB_10975628
Alexa Fluor 488 anti-chicken Thermo Fisher Scientific Cat# A-11039 RRID: AB_2534096
Cyanine3 donkey anti-mouse Jackson ImmunoResearch Cat# 715-165-150, RRID: AB_2340813
Cyanine3 donkey anti-rabbit Jackson ImmunoResearch Cat# 711-165-152, RRID: AB_2307443
Rabbit IgG isotype control Abcam Cat# ab171870, RRID: AB_2687657
Rabbit anti-Bcl6 Santa Cruz Biotechnology Cat# sc-858, RRID: AB_2063450
Rabbit anti-H1.4K26ac Sigma-Aldrich Cat# H7789, RRID: AB_1079058
Rabbit anti-H4K16ac Millipore Cat# 07-329, RRID: AB_310525
Rabbit anti-Sirt1 Millipore Cat# 07-131, RRID: AB_10067921
Rabbit anti-Tcf7l1 Prof. Brad Merrill N/A
Chemicals, Peptides, and Recombinant Proteins
CHIR 99021 Tocris Cat# 4423
Cyclopamine Calbiochem Cat# 239803
Doxycycline hydrochloride Sigma-Aldrich Cat# D3447
ESGRO Recombinant LIF Merck Cat# ESG1107
N-2 Supplement Thermo Fisher Scientific Cat# 17502048
Critical Commercial Assays
HiSeq PE Cluster Kit v4 Illumina Cat# PE-401-4001
RNeasy mini kit QIAGEN Cat# 74104
TruSeq SBS Kit v3-HS Illumina Cat# FC-401-3002
TruSeq stranded mRNA library prep Illumina Cat# RS-122-2101
DIG RNA labeling kit Roche Cat# 11175025910
qPCR Primers
Oligonucleotides Eurogentec See Table S4
Experimental Models: Cell Lines
A2 lox.Cre Bcl6 ES cells Tiberi et al., 2012a N/A
Experimental Models: Organisms/Strains
Mouse: ICR (CD1) Janvier labs Strain code 022
Deposited Data
ChIP-seq This paper GEO: GSE132964
RNA-seq This paper GEO: GSE133031
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REAGENT or RESOURCE SOURCE IDENTIFIER
Software and Algorithms
Bowtie Langmead et al., 2009 https://github.com/BenLangmead/bowtie
EdgeR 3.20.1 Robinson et al., 2010 https://bioconductor.org/packages/release/bioc/
html/edgeR.html
Fiji/ImageJ 1.49b Schindelin et al., 2012 https://fiji.sc/
Genomic HyperBrowser Sandve et al., 2010 https://hyperbrowser.uio.no/hb/
GOrilla http://cbl-gorilla.cs.technion.ac.il
GREAT 3.0 McLean et al., 2010 http://great.stanford.edu/public/html/
HTSeq 0.9.1 Anders et al., 2015 https://github.com/simon-anders/htseq
i-cisTarget Imrichova´ et al., 2015 https://gbiomed.kuleuven.be/apps/lcb/i-cisTarget/
MACS Zhang et al., 2008 https://github.com/taoliu/MACS/
STAR 2.5.3a Dobin et al., 2013 https://github.com/alexdobin/STAR
UCSC Genome Browser Kent et al., 2002 https://genome.ucsc.edu
ZEN Black microscope software Zeiss N/A
Other
Axioplan2 fluorescent microscope Zeiss N/A
LSM780 confocal microscope Zeiss N/A
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Further information and requests for resources and reagents should be directed to, andwill be fulfilled without restriction by, the Lead
Contact Pierre Vanderhaeghen (pierre.vanderhaeghen@kuleuven.vib.be).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
All mouse experiments were performed with the approval of the Universite´ Libre de Bruxelles Committee for animal welfare. Animals
were housed under standard conditions (12 h light:12 h dark cycles) with food and water ad libitum. For in utero electroporation
experiments, timed-pregnant mice were obtained by mating adult RjOrl:SWISS CD1 mice (Janvier, France). The plug date was
defined as embryonic day E0.5. For experiments usingBcl6/mice, wematedBcl6+/mice (mixed C57BL/6 and CD1 background),
in which the null allele lacked exons 4–10 (Ye et al., 1997).
METHOD DETAILS
In Utero Electroporation
Timed-pregnant mice were anesthetized with a ketamine/xylazine mixture at E13.5. Each uterus was cautiously exposed under ster-
ile conditions. Fast-green (Sigma)-labeled plasmid solutions were prepared using either 1 mg/mL or 0.5 mg/mL of appropriate DNA
combinations for gain of function experiments or knockdown experiments, respectively. DNA solutions were injected into the lateral
ventricles of the embryos using a heat-pulled glass capillary (1.0 OD x 0.78 3 100 L mm; Harvard Apparatus) prepared with a heat
micropipette puller (heat: 580, pull: 100, velocity: 170, time: 120, pressure: 500; Sutter Instrument P-87). Electroporation was per-
formed using tweezers electrodes (Nepa Gene CUY650P5) connected to a BTX830 electroporator (5 pulses of 30 V for 100 ms
with an interval of 1 s). Embryos were placed back into the abdominal cavity, and mice were sutured and placed on a heating plate
until recovery.
Mouse ES cells and cortical differentiation
The A2 lox.Cre Bcl6 cell lines, tetracyclin-inducible Bcl6 ICE (A2lox.Cre) mouse Embryonic Stem Cells (Tiberi et al., 2012a), were
routinely propagated on irradiated mouse embryonic fibroblasts in DMEM (Invitrogen) supplemented with 15% ESC-certified fetal
bovine serum (vol/vol, Invitrogen), 0.1 mM non-essential amino acids (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 0.1 mM b-mer-
captoethanol (Sigma), 50 U.ml1 penicillin/ streptomycin and 103 U.ml1 mouse Leukemia Inhibitor Factor (ESGRO). Results were
obtained using three independent clones.
For differentiation, A2 lox.Cre Bcl6 mouse ESCs were plated at low density (20 3 103 ml1) on gelatin-coated coverslips and
cultured as previously described (Gaspard et al., 2009). Briefly, on day 0 of the differentiation, the ES medium was changed toNeuron 103, 1–13.e1–e4, September 25, 2019 e2
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2 days. After 10 days, medium was switched back to DDM. Doxycline treatment (1 mg.ml1) for Bcl6 induction or DMSO (1:1000,
control) was applied for 6,12 or 24 h at day 12. CHIR99021 (4 mM, Tocris) needed to be applied for 48h, i.e., from day 10, to effectively
impact Wnt target genes.
Plasmids
For in situ hybridization, the Ccnd1 coding sequences (888 bp) and the Ccnd2 50UTR+coding sequence (1145 bp) were amplified by
PCR from ESC-derived cortical progenitor cDNA, and the sequences verified and cloned into pGEMT plasmid (Promega). The Axin2
plasmid was a kind gift from Dr I. Garcia (ULB) and the Lmo4 plasmid was a kind gift from Prof. J.L.R. Rubenstein (UCSF), who
received it from Prof. G.N. Gill (UCSD). For in utero electroporations, the Bcl6 coding sequence was amplified by PCR from cDNA
and cloned into pCAG-IRES-GFP (pCIG). The pCAG-D90Ctnnb1 plasmid (N-terminal deletion lacking GSK3-dependent S33, S37
and T41 phosphorylation sites) was obtained from Addgene (plasmid #26645). The pCAG-Ccnd1 and pEF1a-Tcf7l1 plasmids
were kind gifts from Dr C. Dehay and Prof. R. Kageyama, respectively. The shRNA plasmids were cloned downstream of the U6 pro-
moter into the pSilencer2.1-CAG-Venus (pSCV2)-plasmid as previously described (Tiberi et al., 2012a) with the exception of the
Ctnnb1 shRNA plasmid (pLKO.1-puro vector, Sigma). Target sequences were 50-ACTACCGTTGTTATAGGTG-30 (Control; Tiberi
et al., 2012a), 50-TGATGTTCTTCTCAACCTTAA-30 (Bcl6; Tiberi et al., 2012a; Zhang et al., 2007), 50-CCCAAGCCTTAGTAAACAT
AA-30 (Ctnnb1; Mao et al., 2009), 50- AGCCTGCACCAGGACTAC-30 (Hes5; (Lee et al., 2007), 50-CCACAGATGTGAAGTTCATTT-30
(Ccnd1; Jirawatnotai et al., 2011; Yu et al., 2006), 50-CGACTTCAAGTTTGCCATGTA-30 (Ccnd2; Gargiulo et al., 2013) and were
previously validated in the corresponding references.
Immunofluorescence
Embryos were fixed by transcardiac perfusion with freshly-prepared 4% paraformaldehyde (Sigma). Brains were dissected, and
100 mm sections were prepared using a Leica VT1000S vibrosector. Slices were transferred into PBS with 0.5 mg/mL sodium azide
(Sigma), then blocked with PBS supplemented with 3% horse serum (Invitrogen) and 0.3% Triton X-100 (Sigma) during 1 h, and
incubated overnight at 4C with the following primary antibodies: chicken GFP (Abcam, 1:2,000), rabbit Pax6 (Covance, 1:1000),
Sox2 (Santa Cruz Biotechnology, 1:500), PCNA (Millipore, 1:200), phospho-Histone H3 (Abcam, 1:100), Tbr2 (Abcam, 1:500),
Neurod2 (Abcam, 1:500), or mouse b3-tubulin (Tuj1 epitope, Covance, 1:1000). After three washes with PBS/0.1% Triton X-100,
slices were incubated in PBS for 1 h at room temperature and incubated 2 h at room temperature with the appropriated Alexa
488 (1:1,000, Molecular Probes), Cyanine 3 or Cyanine 5 (1:400, Jackson ImmunoResearch) secondary antibodies. Sections were
again washed three times with PBS/0.1% Triton X-100, stained with Hoechst (bisBenzimide H 33258, Sigma) for 5 min and washed
twice in PBS. The sections were next mounted on a Superfrost slide (Thermo Scientific) and dried using a brush before adding
Glycergel mountingmedium (Dako). Imaging was performed using a Zeiss LSM780 confocal microscope controlled by the Zen Black
software (Zeiss).
Transcriptome analyses
Total mRNA from four independent samples from ESc-derived cortical differentiations (day 12 ± doxycycline) was extracted using the
QIAGEN RNeasy mini kit according to the manufacturer’s recommendations. Following RNA quality control assessed on a Bio-
analyzer 2100 (Agilent technologies), the indexed cDNA libraries were prepared using the TruSeq strandedmRNALibrary Preparation
kit (Illumina) following manufacturer’s recommendations. The multiplexed libraries (18 pM) were loaded on flow cells and sequences
were produced using a HiSeq PE Cluster Kit v4 and TruSeq SBS Kit v3-HS from a Hiseq 1500 (Illumina). Approximately 20 million of
paired-end reads per sample were mapped against the mouse reference genome (GRCm38.p4/mm10) using STAR 2.5.3a software
(Dobin et al., 2013) to generate read alignments for each sample. Annotations Mus_musculus.GRCm38.87.gtf were obtained from
ftp.Ensembl.org. After transcript assembling, gene level counts were obtained using HTSeq 0.9.1 (Anders et al., 2015). EdgeR
3.20.1 (Robinson et al., 2010) was then used to calculate the level of differential gene expression. Gene Ontology analyses of biolog-
ical processes were performed using the GOrilla application (http://cbl-gorilla.cs.technion.ac.il).
RT-qPCR
Reverse transcription of mature mRNAs was done with the Superscript II kit (Invitrogen) using the manufacturer’s protocol for oligo
dTs. Quantitative PCR (qPCR) was performed in duplicate using Power Sybr Green Mix (Applied Biosystems) and a 7500 Real-Time
PCR System (Applied Biosystems). Results are presented as linearized Ct values normalized to the housekeeping gene Tbp (2DCt)
and the primers are listed in the Table S4.
In situ RNA hybridization
Whole-mount in situ hybridization as well as on coronal and sagittal cryosections was performed using digoxigenin-labeled RNA
probes (DIG RNA labeling kit, Roche) and alkaline phosphatase revelation (NBT/BCIP kit #SK-5400; Vector) as previously described
(Lambot et al., 2005). The above-mentioned plasmids were linearized and reverse-transcribed to generate the anti-sense probes.
Sense probes were used as a negative control for each gene tested and revealed no specific staining (data not shown). Images
were acquired with a Zeiss Axioplan 2microscope and a Spot RT3 camera using the Spot 5.2 software. For quantifications, littermatee3 Neuron 103, 1–13.e1–e4, September 25, 2019
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4 different litters (Ccnd1). Quantifications of gray densities were done on comparable levels of the dorsal primordium of the frontal
cortex using ImageJ software (Schindelin et al., 2012).
Chromatin Immunoprecipitation
A2 lox.Cre Bcl6 cells and E12.5 Bcl6WT and KO telencephalons were fixed with 1% formaldehyde in phosphate-buffered saline and
then lysed, sonicated, and immunoprecipitated as described previously (Castro et al., 2011). Immunoprecipitations were performed
using IgG isotype control (ab171870, Abcam), Bcl6 (sc-858, Santa Cruz Biotechnology), H1.4K26ac (H7789, Sigma-Aldrich),
H4K16ac (07-329, Millipore), Sirt1 (07-131, Millipore), and Tcf7l1 (kind gift from Prof. Brad Merrill) rabbit antibodies and 50/50 mixed
protein A and protein Gmagnetic Dynabeads (ThermoFisher Scientific). Primers used for ChIP-qPCR were designed to surround the
predicted Bcl6 matrices present in the significant peaks of the ChIP-seq screen and are listed in the Table S4.
ChIP-seq
Following chromatin immunoprecipitation using A2 lox.Cre Bcl6 cells (differentiation day 12, 24h Bcl6 induction using 1 mg.ml1
Doxycline treatment) as described above, ChIP libraries were prepared according to the standard Illumina ChIP-seq protocol and
were sequenced with the Genome Analyzer IIx (Illumina) as previously described (Mateo et al., 2015). Reads from three independent
ChIP-seq experiments were pooled and aligned to mm10 mouse genome assembly using Bowtie (Langmead et al., 2009). Peaks
were then called using MACS (Zhang et al., 2008) with standard parameters with default cutoff p value < 10e-5. Target genes asso-
ciated with peaks were identified by GREAT version 3.0 (McLean et al., 2010). ChIP-seq dataset for the Bcl6-predicted target genes
were visualized using the UCSC Genome Browser (Kent et al., 2002). Search for an enrichment of Bcl6 matrices in the MACS-called
ChIP peaks was performed using i-cisTarget (Imrichova´ et al., 2015) using a promoter-only database.
QUANTIFICATION AND STATISTICAL ANALYSIS
Results are shown as mean ± standard error (SEM) of at least three biologically independent experiments. Student’s unpaired t test
was used for two group comparisons. Analyses of multiple groups were performed by a one-way or two-way analysis of variance
(ANOVA) - as indicated in figure legends - followed by post hocmultiple comparisons using Tukey’s test. Hypothesis testing for over-
lap analysis was performed using the Genomic HyperBrowser (https://hyperbrowser.uio.no/hb/; Sandve et al., 2010). For all tests, a
p value inferior to 0.05 was taken as statistically significant.
DATA AND CODE AVAILABILITY
RNA-seq raw data are shown on Table S5 and the complete dataset is available at GEO repository (GEO: GSE133031). The ChIP-seq
dataset is available at GEO repository (GEO: GSE132964).Neuron 103, 1–13.e1–e4, September 25, 2019 e4
